Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Lindroth, H; Liu, K; Szalacha, L; Ashkenazy, S; Bellelli, G; van, den, Boogaard, M; Caplan, G; Chung, CR; Elhadi, M; Gurjar, M; Heras-La-Calle, G; Hoffman, M; Jeitziner, MM; Krewulak, K; Mailhot, T; Morandi, A; Nawa, RK; Oh, ES; Collet, MO; Paulino, MC; von, Haken, R; Nydahl, P, , WDAD, Study, Team.
World delirium awareness and quality survey in 2023-a worldwide point prevalence study.
Age Ageing. 2024; 53(11): afae248
Doi: 10.1093/ageing/afae248
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Hoffmann Magdalena
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Delirium, an acute brain dysfunction, is proposed to be highly prevalent in clinical care and shown to significantly increase the risk of mortality and dementia. OBJECTIVES: To report on the global prevalence of clinically documented delirium and delirium-related clinical practices in wards caring for paediatric and adult patients in healthcare facilities. DESIGN: A prospective, cross-sectional, 39-question survey completed on World Delirium Awareness Day, 15 March 2023. PARTICIPANTS: Clinicians or researchers with access to clinical data. MAIN OUTCOME AND MEASURE: The primary outcome was the prevalence of clinically documented delirium at 8:00 a.m. (4 h) and 8:00 p.m. (±4 h). Secondary outcomes included delirium-related care practices and barriers to use. Descriptive statistics were calculated and multilevel modelling was completed. RESULTS: 1664 wards submitted surveys from 44 countries, reporting on delirium assessments at 8:00 a.m. (n = 36 048) and 8:00 p.m. (n = 32 867); 61% reported use of validated delirium assessment tools. At 8:00 a.m., 18% (n = 2788/15 458) and at 8:00 p.m., 17.7% (n = 2454/13 860) were delirium positive. Top prevention measures were pain management (86.7%), mobilisation (81.4%) and adequate fluids (80.4%). Frequently reported pharmacologic interventions were benzodiazepines (52.7%) and haloperidol (46.2%). Top barriers included the shortage of staff (54.3%), lack of time to educate staff (48.6%) and missing knowledge about delirium (38%). CONCLUSION AND RELEVANCE: In this study, approximately one out of five patients were reported as delirious. The reported high use of benzodiazepines needs further evaluation as it is not aligned with best-practice recommendations. Findings provide a benchmark for future quality improvement projects and research.
- Find related publications in this database (using NLM MeSH Indexing)
-
Humans - administration & dosage
-
Delirium - epidemiology, diagnosis
-
Prevalence - administration & dosage
-
Cross-Sectional Studies - administration & dosage
-
Prospective Studies - administration & dosage
-
Global Health - administration & dosage
-
Health Knowledge, Attitudes, Practice - administration & dosage
-
Adult - administration & dosage
-
Male - administration & dosage
-
Female - administration & dosage
-
Health Care Surveys - administration & dosage
-
Aged - administration & dosage
-
Surveys and Questionnaires - administration & dosage
- Find related publications in this database (Keywords)
-
global delirium prevalence
-
standard of practice
-
delivery of health care
-
cross-sectional studies
-
older people